Epstein-Barr Virus (EBV) Panel
Comprehensive antibody panel to determine current, past, or recent Epstein-Barr virus infection status and distinguish between acute and chronic EBV infections.
Select Lab Partner
What this test measures
This comprehensive panel measures four specific antibodies that develop in response to Epstein-Barr virus (EBV) infection, providing detailed information about infection status and timing. The viral capsid antigen (VCA) IgM and IgG antibodies, along with EBV nuclear antigen (EBNA) IgG, can distinguish acute from past infection. VCA IgM appears early in EBV infection and usually disappears within four to six weeks, while VCA IgG appears in the acute phase, peaks at 2 to 4 weeks after onset, then persists for life.
The EBV nuclear antigen (EBNA) IgG antibody is particularly useful for determining infection timeline, as it slowly appears 2 to 4 months after onset of symptoms and persists for life. Early antigen (EA) IgG appears in the acute phase and generally falls to undetectable levels after three to six months. Together, these markers help healthcare providers differentiate between primary infection, past infection, reactivation, or susceptibility to EBV, which is essential for proper diagnosis and management of conditions like infectious mononucleosis.
What's included
Who should consider this test
You might consider this test if you are experiencing any of the following:
- Individuals experiencing symptoms of infectious mononucleosis, including persistent fatigue, fever, sore throat, swollen lymph nodes, and body aches, particularly when a standard mono test is negative.
- People who have been exposed to someone with confirmed EBV infection or infectious mononucleosis and want to determine their infection status or susceptibility.
- Patients with unexplained prolonged fatigue or flu-like symptoms that may be related to EBV infection, especially when other causes have been ruled out.
- Healthcare workers, teachers, or others in close contact environments who need to understand their EBV status for occupational health purposes.
- Individuals with compromised immune systems who may be at increased risk for EBV-related complications or reactivation of the virus.
- Pregnant women experiencing viral-like symptoms to help distinguish EBV from other infections that may affect pregnancy outcomes.
- People considering or undergoing organ transplantation, as EBV status can be important for determining infection risk and treatment protocols.
What to expect
Preparation
No special preparation is needed for this test. Individuals should inform their healthcare provider about any medications they are taking, though most medications do not interfere with EBV antibody testing.
Sample Type
A healthcare professional will draw a small blood sample from a vein in the arm using a sterile needle. The procedure typically takes just a few minutes and causes minimal discomfort.
Collection
At the laboratory or clinic, patients will have their identity verified and a small amount of blood drawn into collection tubes. The sample will be processed to separate serum for antibody testing.
Turnaround
Results are typically available within 1-3 business days after the laboratory receives the sample, allowing for prompt evaluation of EBV infection status.
Understanding your results
Using VCA IgG, VCA IgM and EBNA IgG antibodies, it is normally possible to distinguish acute from past infection. The specific pattern of positive and negative antibodies provides important information about infection timing and status.
| Population | Reference Range | Notes |
|---|---|---|
| Adults | Negative/Positive for each antibody component | Results are reported as negative, equivocal, or positive for each of the four antibody types tested |
Reference ranges may vary by laboratory and individual factors. Results should be interpreted by a healthcare provider in the context of your overall health.
What does a “Low” result mean?
Negative results for all EBV antibodies typically indicate that an individual has not been exposed to the Epstein-Barr virus and remains susceptible to infection. People are considered susceptible to EBV infection if they do not have antibodies to the VCA. However, in rare cases, people with active EBV infections may not have detectable EBV-specific antibodies. Negative results should be interpreted in the context of symptoms and clinical presentation, as resolution of illness may occur before diagnostic antibody levels appear.
What does a “High” result mean?
Positive results for different antibody combinations may indicate various infection stages. A primary EBV infection is suggested when anti-VCA IgM is present but EBNA antibody is absent. The presence of antibodies to both VCA and EBNA suggests past infection from several months to years earlier. Detection of early antigen antibody is often a sign of active infection, though about 20% of healthy people may have antibodies against early antigen for years. The specific combination of positive antibodies helps determine whether someone has a current, recent, or past EBV infection.
Privacy & confidentiality
All EBV panel results are completely confidential and protected under HIPAA regulations. Results are not shared with insurance companies, will not appear on insurance explanation of benefits, and are not automatically added to your medical records unless you choose to share them with your healthcare provider.
Frequently asked questions
Related tests
Mononucleosis Test
$39Standard screening test for infectious mononucleosis that may be ordered alongside or before EBV-specific testing
View TestComplete Blood Count (CBC)
$29Often ordered to evaluate blood cell changes characteristic of infectious mononucleosis, including atypical lymphocytes
View TestComprehensive Metabolic Panel
$29May be used to check liver function, as EBV infection can sometimes affect liver enzymes and overall metabolic status
View TestCOVID-19 Antibody Test
$59Helps distinguish EBV-related symptoms from COVID-19, especially when patients have fever and fatigue
View TestRelated conditions
CPT Code: 86663, 86664, 86665, 86665
This test may not be available in: NY, NJ, RI
This page is for informational purposes only and does not constitute medical advice. Always consult with a healthcare provider regarding any health concerns. LevelPanel does not diagnose, treat, or prescribe.
Select Lab Partner
Not sure if this is the right test? Contact our care team for guidance.